Your Procedure Was Supposed to Help You. Not Hurt You
When a Kentucky doctor recommends an endoscopic procedure, the conversation is about diagnosis, treatment, and getting answers. It is not about whether the equipment being used inside your body was designed with a flaw that makes it nearly impossible to clean between patients. That is a conversation most patients never got to have — because Olympus never made sure they could.
Olympus is one of the largest manufacturers of endoscopic medical devices in the world. Their scopes are used every day in hospitals and outpatient surgery centers across Kentucky — in Lexington, Louisville, Bowling Green, Owensboro, Covington, Paducah, Frankfort, and dozens of smaller communities where patients rely on regional medical centers for their care. For years, a serious and documented design flaw in certain Olympus devices allowed dangerous bacteria to survive standard sterilization procedures between patients. Each time a contaminated scope was used, the next patient was unknowingly exposed.
The FDA’s response ultimately reflected the severity of what was happening. The agency recalled at least five separate Olympus products and later issued an import alert blocking more than 50 Olympus devices from entering the United States — among the most sweeping regulatory actions ever directed at a single medical device company. These actions came after years of mounting evidence, a damning U.S. Senate investigation, and thousands of patients who were harmed while regulators and the manufacturer moved too slowly.
At Minner Vines Injury Lawyers, we represent Kentucky people who were failed by corporations that prioritized the bottom line over patient safety. We know how to take on large defendants, and we are currently reviewing Olympus endoscope claims for injured Kentucky residents and their families.
The Design Flaw at the Center of This Case
The problem with Olympus duodenoscopes and other flexible endoscopes is not subtle. These devices contain narrow internal fluid channels, complex hinged elevator mechanisms at the working tip, and mechanical joints that flex repeatedly during procedures. Together, these features create a network of tight spaces and microscopic crevices where organic material — blood, tissue, mucus — can collect and harbor bacteria even after cleaning.
Research published in Gastrointestinal Endoscopy established that multi-drug resistant bacterial transmission between patients occurred even when hospital staff followed Olympus’s own manufacturer-recommended reprocessing instructions exactly as written. This finding was pivotal. It confirmed that the problem was not human error, undertrained staff, or shortcuts taken in the cleaning room. The device itself was the source of the danger — designed in a way that made safe reuse impossible under real-world clinical conditions.
A 2022 report from the Association for the Advancement of Medical Instrumentation (AAMI) reached the same conclusion independently, finding that flexible endoscopes remain uniquely resistant to adequate disinfection among all commonly used medical devices, and that only fundamental design changes at the manufacturing level can adequately protect patients going forward.
What Happens When Contaminated Scopes Are Used
When bacteria survive inside an endoscope and are introduced into a new patient’s body during a procedure, the consequences can be severe and fast-moving. The CDC has directly linked Olympus and similar duodenoscopes to outbreaks of Carbapenem-Resistant Enterobacteriaceae (CRE) — a category of bacteria that resists nearly every antibiotic currently available in clinical medicine. The CDC classifies CRE as an urgent public health threat and reports mortality rates reaching as high as 50% in certain vulnerable patient populations.
Documented CRE outbreaks connected to contaminated endoscopes caused patient deaths at major institutions including UCLA Medical Center and Virginia Mason Medical Center in Seattle — respected facilities with experienced infection control programs that were nonetheless unable to protect patients from a device that was engineered with a fundamental flaw.
For Kentucky patients — particularly older adults, those receiving cancer treatment, patients managing diabetes or kidney disease, or anyone with a weakened immune system — a scope-related infection can escalate with alarming speed into sepsis, multi-organ failure, prolonged hospitalization, or death. These outcomes were preventable. Olympus had the data it needed to act long before many Kentucky patients were harmed, and it did not act quickly enough.
How the Government Responded — And How Long It Took
The Timeline is Clear:
The FDA started receiving reports of patient infections connected to Olympus endoscopes. Independent hospital outbreak investigations in multiple states began pointing to the same manufacturer — with no coordinated public warning issued to patients or providers.
The FDA issued a formal safety communication alerting hospitals to contamination risks associated with duodenoscopes. Despite this public warning, Olympus continued selling the same fundamental device design without making the structural corrections that would have actually protected patients.
A U.S. Senate investigation concluded that Olympus had internal records documenting the contamination problem years before any public disclosure was made. The report criticized both the company and the FDA for allowing patient harm to continue while both parties moved too slowly to respond.
The FDA formally recalled a minimum of five distinct Olympus products as documented evidence of patient harm continued to accumulate. Each recall represented patients — real people in Kentucky and across the country — who had already been exposed to devices the agency ultimately determined were unsafe.
The FDA issued an import alert preventing more than 50 Olympus products from entering the United States — one of the most aggressive regulatory responses ever directed at a single medical device manufacturer and a clear signal of how seriously the agency viewed the ongoing risk to patient safety.
In re: Olympus Corp. Duodenoscope Products Liability Litigation, federal courts allowed mass tort claims to proceed on theories including negligent design, failure to warn, and strict product liability — establishing a legal framework that directly supports the claims of injured patients in Kentucky and nationwide.
Do You Have a Qualifying Claim?
Procedures That May Qualify
Your endoscopic procedure must have taken place in 2018 or later at a Kentucky hospital, outpatient surgical center, or specialty clinic, and medical records must be obtainable to confirm that an Olympus device was used during the procedure. Qualifying procedure types currently include:
- Colonoscopy
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Upper Endoscopy
- Laparoscopy
- Bronchoscopy
- Ureteroscopy
- Hysteroscopy
- Sinus Endoscopy
- Cystoscopy
Not sure which category your procedure falls under? Your discharge paperwork, your insurance company’s explanation of benefits, or a medical records request directed to the facility where your procedure was performed will typically include the procedure type and the equipment used. Our intake team is available to help you figure out what to ask for.
Injuries That May Qualify
Your injury must have required a separate hospitalization or medical appointment following the procedure. Currently qualifying injuries include:
- Bacterial infection requiring hospitalization within 90 days of the procedure
- Sepsis or bacteremia following the procedure
- Drug-resistant superbug such as CRE or resistant E. coli diagnosed within 180 days
- Pneumonia or severe pulmonary infection within 90 days
- Tuberculosis within 90 days of the procedure
- HIV diagnosis within 90 days of the procedure
- Organ or tissue damage or perforation caused by the device
- Internal burning caused by the device during the procedure
- Device component that broke or dislodged inside the body, causing injury or requiring retrieval surgery
- Qualifying hemorrhage following the procedure
- Death resulting from infection or device component failure
What the Intake Process Looks Like — And What to Expect
Reaching out to Minner Vines is the beginning of a review, not a commitment. We want every person who contacts us to understand clearly what happens next and what we will need in order to evaluate the strength of their situation.
We will ask whether you are reaching out for yourself or on behalf of a family member. If you are acting for someone else, we need to confirm you have legal authority to do so — through a power of attorney, guardianship order, or appointment as executor or personal representative of an estate.
We will ask about the type of procedure you had, when it occurred, what medical condition prompted it, and what injuries or illnesses developed afterward. Specific dates and the names of the facilities involved are helpful — the more detail you can provide, the faster our team can assess your situation.
We will ask whether you can obtain medical records confirming that an Olympus product was used. Operative notes, device tracking logs, and procedure reports are the most useful. If you do not currently have these, we can help you understand how to request them from your provider or hospital.
Did your hospital or Olympus send you a written notice about a possible device contamination or failure after your procedure? If so, please locate that letter before submitting your evaluation. Notification letters are among the most valuable pieces of evidence a patient can present and have played a significant role in similar cases.
A brief overview of your health history before and after the procedure gives our team important context. Preexisting conditions do not automatically disqualify a claim — but understanding your full picture helps us anticipate how a defense team might respond and how to position your case most effectively.
We will ask whether you have previously spoken with or retained another attorney about this specific claim. If you are currently represented by another lawyer for the same injury, we are unable to move forward. If that relationship has ended or you only had a preliminary conversation, please share those details so our team has the full picture.
Frequently Asked Questions
A: The most reliable source is your medical records — specifically the operative notes or device tracking documentation maintained by the facility. Kentucky hospitals and licensed surgical facilities maintain records of the devices used during procedures, including manufacturer identification. A written medical records request submitted to the facility should produce this information. If your hospital or physician’s office sent you any written notice after your procedure warning of a possible scope contamination issue, that communication is even more direct confirmation. Our intake team can walk you through exactly what to request and how to frame the request if you are unsure where to start.
A: Yes, and you should not let that clinical opinion stop you from exploring your legal options. The connection between endoscopic procedures and subsequent infections is well-documented in medical research but is routinely missed — or not disclosed — at the treatment level. Physicians focused on treating an active infection are not always looking backward to identify the source, and hospitals have not always been transparent about linking post-procedure illnesses to specific devices. If your infection developed within the qualifying timeframes, meets the severity criteria, and records can confirm an Olympus device was used, a physician’s unrelated determination does not close the legal question. That is exactly what our review is designed to assess.
A: Kentucky’s wrongful death statute provides a legal avenue for surviving family members when a loved one dies as a result of a defective product or another party’s negligence. If your wife developed sepsis within 90 days of her colonoscopy and records can confirm that an Olympus device was used, your family’s situation warrants a thorough and careful review. Under Kentucky law, the claim must be brought by the personal representative of the estate. Our team can explain in plain terms what that means and what steps your family would need to take.
A: Keep that letter somewhere safe and have it ready when you submit your case evaluation. A written notification from a hospital or from Olympus directly acknowledging a possible contamination or device failure is among the most significant evidence a patient can possess. These letters confirm that a risk was identified, that your procedure fell within the affected timeframe, and that you were among the patients known to have been exposed. In past litigation, hospital notification letters have carried substantial evidentiary weight — both in establishing corporate knowledge of the problem and in connecting individual patients to specific devices and incidents.
A: Not necessarily — and this is exactly why you should not make that assumption without speaking to an attorney first. Kentucky’s one-year window is measured from the date you discovered — or reasonably should have discovered — the connection between your injury and the defective device. For patients whose infections developed weeks after their procedure, or who were never told their illness might be scope-related, the discovery date may be later than the date the symptoms first appeared. Calculating that deadline accurately requires a careful look at your specific facts. Do not assume your window has closed before getting a professional assessment.
A: No, and we want to be completely upfront about that. Submitting your information starts a review process — it does not create an attorney-client relationship or obligate either party to anything. Our legal team will carefully evaluate your procedure details, your injuries, your medical history, and the other relevant facts before making any decision about representation. We will give you a direct, honest answer about what we find. We are not in the business of telling people what they want to hear just to get a signature — we give real assessments, and we only take cases we genuinely believe we can help with.
Minner Vines Is Ready to Stand With Kentucky Patients
Kentucky patients trusted their doctors, their hospitals, and the equipment used in their care. Olympus — through deliberate design choices and years of failing to adequately warn the people most affected — violated that trust. The FDA’s regulatory actions, the U.S. Senate’s findings, and the trajectory of federal litigation all point in the same direction: this was preventable, it was concealed, and someone should be held accountable.
Minner Vines Injury Lawyers fights for Kentucky people. We handle serious injury and product liability cases across Lexington, Louisville, Bowling Green, Owensboro, Covington, Paducah, Elizabethtown, Frankfort, and every region of the Commonwealth. We understand Kentucky courts, Kentucky juries, and what it takes to go up against a well-funded corporate defendant and make them answer for what they did.
Your evaluation is completely free. There is no pressure and no obligation. If we take your case, you pay nothing unless we win.